| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0360-3016(82)90517-X |
| P698 | PubMed publication ID | 7085377 |
| P50 | author | Lester J. Peters | Q112452630 |
| Howard D. Thames | Q125119054 | ||
| P2093 | author name string | G H Fletcher | |
| H R Withers | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 219-226 | |
| P577 | publication date | 1982-02-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships | |
| P478 | volume | 8 |
| Q40730575 | 2-CAT: 2-concentric arc technique |
| Q48390613 | A brain tumor dose escalation protocol based on effective dose equivalence to prior experience |
| Q73251625 | A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder |
| Q35083280 | A model of photon cell killing based on the spatio-temporal clustering of DNA damage in higher order chromatin structures. |
| Q71223810 | A new isoeffect curve for change in dose per fraction |
| Q71977062 | A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis |
| Q37335783 | A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). |
| Q38998466 | A rat model of radiation injury in the mandibular area |
| Q33964210 | A shorter fractionation schedule for postlumpectomy breast cancer patients |
| Q57812168 | Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety |
| Q44887355 | Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas |
| Q35571229 | Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. |
| Q98771161 | Advances in Radiobiology of Stereotactic Ablative Radiotherapy |
| Q70957519 | Advances in radiation therapy for brain tumors |
| Q33942619 | Advances in radiotherapy for carcinoma of the head and neck. |
| Q47202669 | Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx |
| Q36147403 | Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx |
| Q56060727 | Altered fractionation trials in head and neck cancer |
| Q74510588 | Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer |
| Q42021299 | Alternative models for the proliferative structure of normal tissues and their response to irradiation |
| Q41461765 | An explanatory hypothesis for early- and late-effect parameter values in the LQ model. |
| Q52647867 | Analysis of the rate of expression of radiation-induced renal damage and the effects of hyperfractionation. |
| Q36235453 | Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complicati |
| Q34091010 | Biological aspects of conformal therapy |
| Q42912522 | Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer |
| Q42912231 | Biological equivalence between LDR and PDR in cervical cancer: multifactor analysis using the linear-quadratic model |
| Q35151872 | Biological response to radiation therapy |
| Q27010961 | Cancer concepts and principles: primer for the interventional oncologist-part II |
| Q35591847 | Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation |
| Q73232500 | Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy |
| Q51442140 | Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications. |
| Q89565308 | Cardiovascular diseases in survivors of childhood cancer |
| Q38598903 | Cell kinetics and radiation pathology |
| Q74107380 | Change in radiosensitivity with fractionated-dose irradiation of carbon-ion beams in five different human cell lines |
| Q37500906 | Characterization of H460R, a Radioresistant Human Lung Cancer Cell Line, and Involvement of Syntrophin Beta 2 (SNTB2) in Radioresistance. |
| Q34501938 | Chemoradiation schedules--what radiotherapy? |
| Q50093063 | Commemoration of Jack Fowler's life, work, impact and legacy. |
| Q67867655 | Comments on “predicting normal tissue injury in radiation therapy” |
| Q39732840 | Complications of radiation therapy and factors in their prevention |
| Q93600542 | Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck |
| Q33500817 | Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors |
| Q77451468 | Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue |
| Q36524705 | Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma |
| Q47568735 | Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending? |
| Q52042696 | Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia. |
| Q36291475 | Dose-response and dose-latency relationships for human skin after various fractionation schedules |
| Q70686635 | Dose-response curve and split-dose recovery in human skin cancer |
| Q46110288 | Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx. |
| Q36291437 | Effect of dose per fraction on the division potential of lethally irradiated plateau-phase CHO cells exposed to isoeffective fractionation regimens |
| Q41328529 | Effect of dose-rate on the survival of murine spermatogonia following 60Co gamma-irradiation |
| Q35215796 | Effects of radiation on normal tissue: consequences and mechanisms. |
| Q26774616 | Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer |
| Q75216223 | Endothelial-cell apoptosis and tumour response to radiotherapy |
| Q64089105 | Establishment and characterization of a radiation-induced dermatitis rat model |
| Q35186584 | Estimation of α/β for late rectal toxicity based on RTOG 94-06 |
| Q52424746 | Experimental study on the fractionation schedule for proton irradiation of uveal melanoma. |
| Q28282037 | Exploring the role of cancer stem cells in radioresistance |
| Q36611916 | Exploring two two-edged swords |
| Q41768994 | External beam radiotherapy for primary spinal cord tumors |
| Q72399849 | Fractionated Radiation Therapy after Strandqvist |
| Q70540428 | Fractionated total body irradiation: some radiobiological considerations |
| Q68931251 | Fractionated versus low dose-rate total body irradiation. Radiobiological considerations in the selection of regimes |
| Q71217569 | G2 arrest following fractionated irradiation in the mouse jejunal crypt |
| Q59128815 | Gamma Knife Management of Skull Base Chordomas: Is it a Choice? |
| Q34031417 | Genitourinary rhabdomyosarcoma. Treatment options |
| Q53050456 | High dietary iron increases oxidative stress and radiosensitivity in the rat retina and vasculature after exposure to fractionated gamma radiation. |
| Q41609171 | Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study |
| Q48847451 | Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors |
| Q41634067 | Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma. |
| Q55478814 | Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. |
| Q68290911 | Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: Tolerance and toxicity |
| Q41482096 | Hyperfractionation: where do we stand? |
| Q41089758 | Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells |
| Q31055408 | Hypofractionated irradiation for non-small cell lung cancer |
| Q38226822 | Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. |
| Q43734186 | Hypofractionation reduces the therapeutic ratio in early glottic carcinoma |
| Q40959958 | Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002. |
| Q37139905 | Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy. |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q73516933 | Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma |
| Q47136485 | Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3. |
| Q83922534 | Inverse plan optimization accounting for random geometric uncertainties with a multiple instance geometry approximation (MIGA) |
| Q33757638 | Issues in the management of nasopharyngeal carcinoma |
| Q40151365 | Keynote address: The scientific basis of the present and future practice of clinical radiotherapy |
| Q55340786 | Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. |
| Q48530736 | Klaas Breur memorial lecture 1986. Differences in radiosensitivity among cells in culture and in experimental tumours: significance for the effectiveness of human cancer therapy |
| Q68974123 | Lack of differential sparing of late ischaemic atrophy and early epidermal healing, after dose fractionation of mouse tails down to 2.6 Gy per fraction |
| Q53803554 | Large bowel stenosis in rats after fractionated local irradiation. |
| Q68547184 | Late functional, biochemical and histological changes in the rat lung after fractionated irradiation to the whole thorax |
| Q46308192 | Late reaction following twice-a-day irradiations in the murine foot: Possible repopulation or consequential late effect |
| Q70078853 | Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group |
| Q64997111 | Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. |
| Q48464408 | Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study |
| Q33784185 | Long-term complications with prostate implants: iodine-125 vs. palladium-103. |
| Q42155532 | Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer |
| Q36291378 | Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs |
| Q64243093 | Mechanistic Modelling of Radiation Responses |
| Q48632169 | Misonidazole combined with hyperfractionation in the management of malignant glioma |
| Q98242869 | Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature |
| Q70686640 | Multifraction irradiation of mouse bladders |
| Q36745997 | Multiple fraction-per-day radiotherapy for patients with brain stem tumors |
| Q70686555 | Multiple small fractions per day versus conventional fractionation. Comparison of normal tissue reactions and effect on breast carcinoma |
| Q44704525 | No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer |
| Q77639209 | No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy |
| Q81149376 | Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy |
| Q71623991 | Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology |
| Q37145905 | Osteochondroma in long-term survivors of high-risk neuroblastoma |
| Q37446921 | Outcome and prognostic factors of childhood diffuse brainstem glioma |
| Q58603211 | Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial |
| Q93600550 | Patterns of cell loss and repopulation in irradiated cultures of plateau phase C3H 10T 1/2 cells |
| Q55484778 | Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. |
| Q68447416 | Pelvic Rhabdomyosarcoma in Children |
| Q31148353 | Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases. |
| Q30660196 | Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli |
| Q31861401 | Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme |
| Q72073746 | Phase I–II study of multiple daily fractions for palliation of advanced head and neck malignancies |
| Q68913465 | Postoperative radiotherapy of carcinoma in bilharzial bladder using a three-fractions per day regimen |
| Q47147816 | Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions |
| Q34507660 | Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-di |
| Q34571941 | Programming of radiotherapy in the treatment of non-small-cell lung cancer--a way to advance care |
| Q47153259 | Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model. |
| Q83213816 | Radiation induced brachial plexopathies |
| Q70508332 | Radiation induced renal damage in mice: influence of overall treatment time |
| Q40849771 | Radiation injuries of the colon and rectum |
| Q55038981 | Radiation oncology: a century of achievements. |
| Q34305582 | Radiation response of the central nervous system |
| Q71931107 | Radiation therapy for malignant melanoma |
| Q35145698 | Radical radiotherapy for prostate cancer |
| Q52631475 | Radiobiological considerations in the treatment of neuroblastoma by total body irradiation. |
| Q33922093 | Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases |
| Q27022685 | Radiotherapy and the tumor stroma: the importance of dose and fractionation |
| Q34992802 | Radiotherapy for cancer of the head and neck: altered fractionation regimens |
| Q33782166 | Radiotherapy in bladder cancer |
| Q41131710 | Recent trends in the radiotherapy of pediatric gliomas |
| Q33658099 | Relative biological effectiveness of proton beams in clinical therapy |
| Q52698312 | Repair factors for multifraction irradiations. |
| Q69529491 | Response of human tumour xenografts to fractionated X-irradiation |
| Q39997293 | Response to multiple radiation doses of fibroblasts over-expressing dominant negative Ku70. |
| Q39699032 | Response to multiple radiation doses of human colorectal carcinoma cells infected with recombinant adenovirus containing dominant-negative Ku70 fragment |
| Q93577929 | Retinopathy after irradiation and hyperbaric oxygen |
| Q33782351 | Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study |
| Q70686647 | Split-dose recovery in epithelial and vascular-connective tissue of pig skin |
| Q33812371 | Squamous cell carcinomas of the head and neck |
| Q41159739 | Stage-directed treatment guidelines |
| Q40978262 | The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer |
| Q39200876 | The Role of Hypofractionated Radiotherapy in Prostate Cancer |
| Q69735752 | The acute in vitro and in vivo radiosensitivity of human lung tumour lines |
| Q37211721 | The contribution of women to radiobiology: Marie Curie and beyond |
| Q88106363 | The evolution of practical radiobiological modelling |
| Q40169933 | The first James Kirk memorial lecture. What next in fractionated radiotherapy? |
| Q93600555 | The influence of overall treatment time on renal injury after multifraction irradiation |
| Q43563366 | The life shortening effects of treatment with doxorubicin and/or local irradiation on a cohort of young C3Hf/Sed mice |
| Q70497548 | The role of radiation in the treatment of cancer:radiobiologic and cell kinetic concepts |
| Q48540950 | The second Klaas Breur memorial lecture. La Ronde--radiation sciences and medical radiology |
| Q52431666 | The sensitivity of normal stroma to fractionated radiotherapymeasured by a tumour growth rate assay |
| Q40727895 | The translational research chain: is it delivering the goods? |
| Q54147600 | The use of a concomitant electron boost (field in the field technique) in large cervical node metastases over a shortened period. |
| Q39294829 | Theoretical implications of incorporating relative biological effectiveness into radiobiological equivalence relationships |
| Q48245734 | There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherap |
| Q43694227 | Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy |
| Q42171003 | Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. |
| Q74272740 | Toward optimal external-beam fractionation for prostate cancer |
| Q58130524 | Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation |
| Q70578727 | Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience |
| Q71959858 | Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: A nonrandomized comparison of treatment results |
| Q36317335 | Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma |
| Q92645283 | Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management |
| Q38118440 | Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases |
| Q84830926 | [A century of development in radiation biology. Basic principles of targeted and efficient radiotherapy] |
| Q77537113 | [A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice] |
| Q74617390 | [Biological mechanisms of late effects of ionizing radiations] |
| Q73611596 | [Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients] |
| Q74617420 | [Late effects of mammary radiotherapy on skin and subcutaneous tissues] |
Search more.